Compare UK prices. 40+ products · 25 retailers scored
PeptideClear UK

Regulatory hub · UK status

Tirzepatide: UK regulatory status

Also known as: Mounjaro, Zepbound

Last reviewed . Editorial commentary, not legal advice.

MHRA: Prescription Only Medicine Not currently listed on the WADA Prohibited List
AI-friendly summary · Tirzepatide

As of July 2026, tirzepatide is a Prescription Only Medicine in the UK with MHRA marketing authorisation for type 2 diabetes and chronic weight management. It is not a controlled drug. Branded promotion to the public is prohibited under ASA and MHRA rules for POM, a position MHRA, ASA and GPhC restated in a joint warning on 18 June 2026.

Misuse of Drugs Act 1971

Tirzepatide does not appear on any schedule of the Misuse of Drugs Act 1971.

Psychoactive Substances Act 2016

Tirzepatide is not covered by the Psychoactive Substances Act 2016.

MHRA and medicines classification

As of July 2026, tirzepatide is classified as a Prescription Only Medicine under the Human Medicines Regulations 2012. UK marketing authorisation is held by the originator manufacturer. It is dispensed through registered UK pharmacies on a valid prescription from a qualified UK prescriber. Supply outside that route is a live enforcement area: on 24 February 2026 MHRA issued an alert on fake tirzepatide KwikPen 15mg pens (batch D873576) dispensed by a Birmingham pharmacy, and on 29 May 2026 it reported its largest ever seizure of unlicensed weight-loss medicines, around 12,000 doses including tirzepatide.

See: MHRA medicines classification (POM, P, GSL).

WADA Prohibited List position

Tirzepatide is not currently named on the WADA Prohibited List. Tested athletes should consult WADA and their federation directly.

See: WADA Prohibited List and peptides.

ASA advertising framing

POM medications cannot be advertised to the public under the Human Medicines Regulations 2012. UK clinics may state they offer "weight loss treatment" or "GLP-1 medications" generically; named-brand promotion to the public is prohibited.

See: ASA rules on weight-loss advertising.

Frequently asked questions

Is Tirzepatide legal in the UK?
As of July 2026, tirzepatide is a Prescription Only Medicine in the UK with MHRA marketing authorisation for type 2 diabetes and chronic weight management. It is not a controlled drug. Branded promotion to the public is prohibited under ASA and MHRA rules for POM, a position MHRA, ASA and GPhC restated in a joint warning on 18 June 2026.
What is the MHRA position on Tirzepatide?
As of July 2026, tirzepatide is classified as a Prescription Only Medicine under the Human Medicines Regulations 2012. UK marketing authorisation is held by the originator manufacturer. It is dispensed through registered UK pharmacies on a valid prescription from a qualified UK prescriber. Supply outside that route is a live enforcement area: on 24 February 2026 MHRA issued an alert on fake tirzepatide KwikPen 15mg pens (batch D873576) dispensed by a Birmingham pharmacy, and on 29 May 2026 it reported its largest ever seizure of unlicensed weight-loss medicines, around 12,000 doses including tirzepatide.
Is Tirzepatide on the WADA Prohibited List?
Tirzepatide is not currently named on the WADA Prohibited List. Tested athletes should consult WADA and their federation directly.
What can UK sellers say about Tirzepatide in adverts?
POM medications cannot be advertised to the public under the Human Medicines Regulations 2012. UK clinics may state they offer "weight loss treatment" or "GLP-1 medications" generically; named-brand promotion to the public is prohibited.

Related: Tirzepatide editorial entry · UK regulatory hub.

Reviewed by Oliver Mackman, editorial director · last reviewed 2026-07-19T12:00:00.000Z
Trust, Legal and Governance

PeptideClear is a trading name of Best Business Loans Ltd, registered in England and Wales (company number 16833937). All services, operations and publications under the PeptideClear brand are delivered by Best Business Loans Ltd.

Legal and Registration

Registered in England and Wales. Company number 16833937. D‑U‑N‑S 234324824. ICO registered, reference ZC151816 (certificate, verify). Registered supplier on the UK Government's Find a Tender Service (FTS). Details publicly available via Companies House and OpenCorporates.

Standards and Governance

Operates under UK data protection and consumer standards. Aligns with UK GDPR, ISO 27001 and ISO 9001 principles. Working towards Cyber Essentials certification.

Domain Continuity

Primary domain peptideclear.co.uk. Business ownership, entity and services remain unchanged. Reviewed quarterly.